Valdecoxib CAS 181695-72-7 Kuchena > 99.5% (HPLC)
Shanghai Ruifu Chemical Co., Ltd. ndiyo inotungamira mugadziri uye mutengesi weValdecoxib (CAS: 181695-72-7) ine mhando yepamusoro.Isu tinogona kupa COA, kuendesa pasi rese, zvidiki uye huwandu hwakawanda huripo.Kana iwe uchifarira chigadzirwa ichi, ndapota tumira ruzivo rwakadzama runosanganisira nhamba yeCAS, zita rechigadzirwa, huwandu kwatiri.Please contact: alvin@ruifuchem.com
| Chemical Name | Valdecoxib |
| Mashoko anoreva zvakafanana | Bextra;SC 65872;Valus;Valz;4-(5-Methyl-3-Phenyl-4-Isooxazolyl)benzenesulfonamide;4-(5-Methyl-3-Phenyl-1,2-Oxazol-4-yl)benzenesulfonamide;4-(5-Methyl-3-Phenylisoxazol-4-yl)benzenesulfonamide |
| Nhamba yeCAS | 181695-72-7 |
| Nhamba yeCAT | RF2833 |
| Stock Status | MuStock, Kugadzirwa Kunokwira Kusvika Matani |
| Molecular Formula | C16H14N2O3S |
| Molecular Weight | 314.36 |
| Melting Point | 162.0~167.0℃ |
| Boiling Point | 481.2±55.0℃ |
| Density | 1.303±0.06 g/cm3 |
| Sensitive | Heat Sensitive |
| Mvura Solubility | Insoluble muMvura |
| Solubility | Soluble muEthanol, Methanol |
| Storage Temp. | Room Temperature |
| Brand | Ruifu Chemical |
| Item | Zvinotsanangurwa |
| Chitarisiko | White kana Off-White Powder |
| Kuchena / Analysis Method | >99.5% (HPLC) |
| Melting Point | 162.0~167.0℃ |
| Mvura (naKarl Fischer) | <0.50% |
| Residue paIgnition | <0.20% |
| Kusachena Kumwechete | <0.30% |
| Zvose Zvisina Kuchena | <0.50% |
| Heavy Metals (as Pb) | <20ppm |
| Infrared Spectrum | Inopindirana neChimiro |
| NMR Spectrum | Inopindirana neChimiro |
| Test Standard | Enterprise Standard |
| Usage | API, A Second-Generation COX-2 Inhibitor |
Package: Bhodhoro, Aluminium foil bag, 25kg/Cardboard Drum, kana zvinoenderana nezvinodiwa nemutengi.
Storage Condition:Chengetedza mumidziyo yakavharwa panzvimbo inotonhorera uye yakaoma;Dzivirira kubva kuchiedza uye unyoro
Kutenga sei?Please contact: sales@ruifuchem.com or alvin@ruifuchem.com
Makore 15 Oupenyu?Tine makore anopfuura 15 ane ruzivo mukugadzira uye kutumira kunze kwemhando dzakasiyana-siyana dzepamusoro dzemishonga yepakati kana makemikari akanaka.
Main Markets?Tengesa kumusika wepamba, North America, Europe, India, Korea, Japan, Australia, nezvimwe.
Zvakanakira?Hunhu hwepamusoro, mutengo unokwanisika, masevhisi ehunyanzvi uye rutsigiro rwehunyanzvi, kuendesa nekukurumidza.
HunhuSimbiso?Strict quality control system.Midziyo yehunyanzvi yekuongorora inosanganisira NMR, LC-MS, GC, HPLC, ICP-MS, UV, IR, OR, KF, ROI, LOD, MP, Clarity, Solubility, Microbial limit test, nezvimwe.
Samples?Zvigadzirwa zvakawanda zvinopa mahara emahara ekuongorora kwemhando, mutengo wekutumira unofanirwa kubhadharwa nevatengi.
Factory Audit?Factory audit inogamuchirwa.Ndapota itai nguva isati yasvika.
MOQ?Hapana MOQ.Kurongeka kudiki kunogamuchirwa.
Delivery Nguva? Kana mukati me stock, mazuva matatu kutumirwa anovimbiswa.
Transportation?Ne Express (FedEx, DHL), neMhepo, neGungwa.
Zvinyorwa?Mushure mekutengesa sevhisi: COA, MOA, ROS, MSDS, nezvimwe zvinogona kupihwa.
Custom Synthesis?Inogona kupa echinyakare synthesis masevhisi kuti aenderane nezvinodiwa zvako zvekutsvagisa.
Payment Terms?Proforma invoice inozotumirwa kutanga mushure mekusimbisa kurongeka, yakavharirwa ruzivo rwedu rwebhangi.Kubhadhara neT/T (Telex Transfer), PayPal, Western Union, nezvimwe.
Valdecoxib (CAS: 181695-72-7) chizvarwa chechipiri COX-2 inhibitor, yakagadziridzwa seyekutevera kune celecoxib yemuromo kamwe-zuva kurapwa kweosteoarthritis, mukuru rheumatoid arthritis uye kurwadziwa kwekuenda kumwedzi.Valdecoxib inenge 28,000-yakapetwa zvakanyanya kusarudzwa kupikisa munhu recombinant COX-2 pane yemunhu recombinant COX-1.Mune ex viva yemunhu ropa rese assay, iyo I&O kukosha inopesana neCOX-2 uye COX-1 yaive zvakateerana 0.89 PM uye 25.4 FM.Mune mhando dzemhuka, valdecoxib ine yakanakisa kuita yemuromo senge antiinflammatory.Mumakonzo, valdecoxib ine simba inhibited carrageenan footpad edema uye adjuvant-induced arthritis.Valdecoxib is nonsteroidal anti-inflammatory drug (NSAID) iyo inoratidza anti-inflammatory, analgesic uye antipyretic properties mumhando dzemhuka.Iyo ine simba uye inosarudza inhibitor ye prostaglandin synthesis kunyanya kuburikidza nekudzivisa COX-2.Valdecoxib inoshandiswa kubvisa zvimwe zviratidzo zvinokonzerwa nearthritis (rheumatism), zvakadai sekuzvimba, kuzvimba, kuoma, uye kurwadziwa kwemajoini.Valdecoxib inotenderwa kuzorora kwezviratidzo uye zviratidzo zveosteoarthritis uye yevakuru rheumatoid arthritis uye nekurapa kwekutanga dysmenorrhea.Valdecoxib inorambidzwa kurapwa kwemarwadzo epashure nekukurumidza mushure mekuvhiyiwa kwegoronary artery bypass graft.
